Search Login Register

Hyperhidrosis Summary

Description: Excessive sweating. In the localized type, the most frequent sites are the palms, soles, axillae, inguinal folds, and the perineal area. Its chief cause is thought to be emotional. Generalized hyperhidrosis may be induced by a hot, humid environment, by fever, or by vigorous exercise.

Key Drugs and Agents for Hyperhidrosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Botulinum Toxins (Botulinum Toxin) : 53 outcomes 30 studies in 226 results : IBA
  2. Type A Botulinum Toxins (Botulinum A Toxin) : 27 outcomes 20 studies in 113 results : FDA 2
  3. oxybutynin (Tavor) : 13 outcomes 7 studies in 32 results : FDA 22 Generic
  4. onabotulinumtoxinA (Botox) : 8 outcomes 10 studies in 36 results : FDA 1
  5. Glycopyrrolate (Glycopyrronium Bromide) : 7 outcomes 5 studies in 25 results : FDA 21 Generic
  6. abobotulinumtoxinA : 6 outcomes 3 studies in 16 results : FDA 2
  7. aluminum chloride : 6 outcomes 2 studies in 38 results : IBA
  8. TES : 4 outcomes 3 studies in 20 results : IBA
  9. rimabotulinumtoxinB : 4 outcomes 1 study in 12 results : FDA 2
  10. batrachotoxinin A 20-alpha-benzoate : 3 outcomes 1 study in 5 results : IBA
Show All >>

Diseases Related to Hyperhidrosis

  1. Pain (Aches)
  2. Gustatory Sweating (Frey's Syndrome)
  3. Sialorrhea
  4. Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome)
  5. Raynaud Disease (Raynaud's Disease)
Show All >>

Key Therapies for Hyperhidrosis

Efficacy Chart >>
  1. Sympathectomy (Sympathectomies) : 94 outcomes 75 studies in 594 results
  2. Injections : 15 outcomes 12 studies in 75 results
  3. Curettage : 7 outcomes 6 studies in 20 results
  4. Intradermal Injections : 5 outcomes 4 studies in 29 results
  5. Aftercare (After-Treatment) : 5 outcomes 2 studies in 23 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.